Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease-Reference-Cited by-同舟云学术

Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease

Published:2023 Issue:26 Volume:13 Page:17526-17535
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Naseem Saira¹,Temirak Ahmed²^ORCID,Imran Aqeel³⁴^ORCID,Jalil Saquib³,Fatima Shamool¹,Taslimi Parham⁵^ORCID,Iqbal Jamshed³⁶^ORCID,Tasleem Mussarat¹^ORCID,Tahir Muhammad Nawaz⁷^ORCID,Shafiq Zahid¹^ORCID

Affiliation:

1. Institute of Chemical Sciences, Bahauddin Zakariya University, Multan, 60800, Pakistan

2. National Research Centre, Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, Dokki, Cairo P.O. Box 12622, Egypt

3. Centre for Advanced Drug Research, COMSATS University Islamabad, Abbottabad Campus, Abbottabad-22060, Pakistan

4. Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Punjab, 54000, Pakistan

5. Department of Biotechnology, Faculty of Science, Bartin University, 74100 Bartin, Turkey

6. Department of Chemistry, COMSATS University Islamabad, Abbottabad Campus, Abbottabad-22060, Pakistan

7. Department of Physics, University of Sargodha, Sargodha, Pakistan

Abstract

Monoamine oxidase and cholinesterase enzymes are important targets for the treatment of several neurological diseases especially depression, Parkinson disease and Alzheimer's.

Funder

Higher Education Commision, Pakistan

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/RA/D3RA01953E

Reference31 articles.

1. Global Burden of Neurological Disorders: From Global Burden of Disease Estimates to Actions

2. Synthesis, molecular docking, acetylcholinesterase and butyrylcholinesterase inhibitory potential of thiazole analogs as new inhibitors for Alzheimer disease

3. Alzheimer’s disease hypothesis and related therapies